结构引导的三角类阿片类受体的全调节
Jesse I Mobbs1,2,3, M Deborah Nguyen1,3, Owindeep Deo1,3
1Monash Institute of Pharmaceutical Sciences, Parkville, Australia.
bioRxiv : the preprint server for biology
|November 24, 2025
概括
研究人员使用冷EM发现了delta-opioid受体 (δOR) 上的一个新的结合部位. 这一发现使得能够开发出更安全的止痛药,通过积极的全调节剂 (PAMs) 向 δOR.
科学领域:
- 结构生物学 结构生物学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 类阿片类止痛药对于缓解疼痛至关重要,但会引起呼吸抑制,耐受性和依赖性等不良影响.
- 与传统的mu-opioid受体药物相比,delta-opioid受体 (δOR) 是一种更安全的止痛药的潜在目标.
- 积极的全调节剂 (PAMs) 提供了一种增强自然阿片类药物信号的方法,可能减轻耐受性和依赖性.
研究的目的:
- 为了确定与激动剂和PAM复合的 δOR 的高分辨率结构.
- 通过一种新的PAM阐明 δOR全调节的分子机制.
- 为设计改进,更安全的阿片类药物治疗提供结构性基础.
主要方法:
- 高分辨率冷电子显微镜 (cryo-EM) 用于可视化 δOR - 连接体复合体.
- 变异性研究,分子动力学模拟和结构-活性关系 (SAR) 分析.
- 结构导向优化以开发新的PAMs.
主要成果:
- 揭示了一种新的面向脂质的全结合部位,用于PAM MIPS3614,涉及跨膜螺旋体2,3和4.
- 证明MIPS3614通过在结合部位与残留N1313.35的键稳定了活性 δOR 构造.
- 验证了全调节机制,并开发了一种优化的化合物,MIPS3983,具有增强的特性.
结论:
- 建立了第一个dOR全调节的分子框架.
- 确定了涉及GPCR激活结合部位的关键相互作用.
- 为合理设计更安全的 δOR 向止痛药提供了结构性基础.
相关概念视频
Opioid Receptors: Overview
3.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.9K
Allosteric Regulation
62.8K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
62.8K
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Cooperative Allosteric Transitions
8.6K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.6K
Cooperative Allosteric Transitions
2.6K
2.6K
The Two-State Receptor Model
3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.0K


